Study of 68Ga-R10602

ClinicalTrials.gov ID: NCT06745804

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT06745804. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:50 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1 Imaging Study of 68Ga-R10602-101 in Hormone Receptor-Positive Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A phase 1 imaging study of 68Ga-R10602 in hormone-receptor positive breast cancer.

Study identification

NCT ID: NCT06745804
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Radionetics Oncology; Industry
Enrollment: 27 participants

Conditions and interventions

Conditions

Interventions

68Ga-R10602 injection Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 10, 2024 (Actual)
Primary completion: May 4, 2026 (Actual)
Completion: May 4, 2026 (Actual)
Last update posted: Jul 6, 2026

2024 – 2026

United States locations

U.S. sites: 6
U.S. states: 6
U.S. cities: 6

Facility	City	State	ZIP	Site status
UCLA Department of Medicine - Hematology/Oncology	Los Angeles	California	90095	—
Indiana University Melvin and Bren Simon Cancer Center	Indianapolis	Indiana	46202	—
University of Iowa	Iowa City	Iowa	52242	—
University of Michigan Medicine	Ann Arbor	Michigan	48109	—
MD Anderson Cancer Center	Houston	Texas	77030	—
University of Utah, Huntsman Cancer Institute	Salt Lake City	Utah	844112	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06745804, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 6, 2026 · Synced Nov 15, 2026